• Building our
    future together

    General Information

    Our
    mission

    Our mission is to provide patients in all regions of Russia with access to the most innovative
    and modern medical products used for treatment of high burden diseases.

    Our Core
    Values

    Honesty and Integrity
    Responsibility at work
    Drive and initiative
    Desire for
    self-improvement
    Transparency and
    ethical business

    OUR
    ACHIEVEMENTS

    • Russian Drugs Procurement has reached 475 Bln RUR (2018) with CAGR 7%
    • Since its foundation in 2013 Pharmforward has been performing with CAGR of 76%
    • Pharmforward’s Evolution Index is 1,32 (2015 - 2018)

    Therapeutic
    areas

    Oncology
    28%
    Anti-infectives
    23%
    Endocrinology, including Diabetes
    12%
    Diagnostics, including contrast media
    11%
    Other hospital care
    9%
    • Russian government spends 65% of it’s healthcare budget on oncology, anti-infectives and diabetes drug procurements
    • Pharmforward’s portfolio consists of 15 therapeutic areas but main focus has been on oncology, anti-infectives, diabetes and immunomodulatory drug segments

    Partners

    Pharmforward conducts its business openly, professionally and efficiently. We partner with global pharmaceutical companies, leading Russian manufacturers and medical professional associations.

    What we offer our partners

    Geography

    We are present in all Federal regions and big cities
    of the Russian Federation

    Management
    Team